BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 852469)

  • 21. Effectiveness of simplified dosage schedules on the management of ambulant epileptic patients.
    Zaccara G; Galli A
    Eur Neurol; 1979; 18(5):341-4. PubMed ID: 527610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radioimmunologic study of the plasma concentrations of folic acid and various antiepileptic preparations during the treatment of epileptic patients].
    Boldarov AI; Maĭzelis MIa; Vaĭntrub MIa; Zabludovskiĭ AL; Gvirtsman LE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):845-8. PubMed ID: 6880514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state serum levels of anticonvulsant drugs in Chinese epileptic patients living in Taiwan.
    Lai ML
    Ther Drug Monit; 1985; 7(1):83-6. PubMed ID: 3992625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monitoring plasma levels of some antiepileptic drugs (phenobarbital, diphenylhydantoin, carbamazepine) in the Lennox-Gastaut syndrome and in other forms of epilepsy (partial and secondary generalized) in childhood].
    Viani F; Gerna M; Riboldi A; Rossotti V; Morselli PL
    Riv Neurol; 1975; 45(2):189-98. PubMed ID: 809828
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of serum levels during prolonged combination therapy with phenytoin and phenobarbitone.
    Müller FO; Aucamp AK; Hundt HK; Steyn JM; Olivier LR; Wessels WH
    S Afr Med J; 1977 Aug; 52(9):356-8. PubMed ID: 897947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy.
    Lambie DG; Johnson RH; Nanda RN; Shakir RA
    Lancet; 1976 Aug; 2(7982):386-9. PubMed ID: 73851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effect of clonazepam on serum levels of diphenylhydantoin, phenobarbital and carbamazepine.
    Johannessen SI; Strandjord RE; Munthe-Kaas AW
    Acta Neurol Scand; 1977 Jun; 55(6):506-12. PubMed ID: 878840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].
    Benetello P; Testa G; Furlanut M
    Clin Ter; 1978 Apr; 85(1):11-8. PubMed ID: 657740
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical value of determination of serum concentration of antiepileptics.
    Wang L; Zuo QH; Liu SR; Wang SH
    Chin Med J (Engl); 1984 Mar; 97(3):165-70. PubMed ID: 6432478
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of epilepsy in the light of determinations of the blood levels of anticonvulsants.
    Majkowski J
    Pol Med J; 1972; 11(1):202-7. PubMed ID: 5040998
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anti-convulsant drugs.
    Braide SA; Davies TJ
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():391-9. PubMed ID: 2889417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenytoin and phenobarbitone plasma level-dose relationships in Chinese epileptic children in Singapore.
    Lee HS; Chan KY
    Ther Drug Monit; 1981; 3(3):247-52. PubMed ID: 7324089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic response relationship to phenobarbital and diphenylhydantoin serum and cerebrospinal fluid levels in epileptics.
    Volanschi D; Pintilie C; Florescu D; Tudor S
    Neurol Psychiatr (Bucur); 1975; 13(3):217-23. PubMed ID: 1188280
    [No Abstract]   [Full Text] [Related]  

  • 35. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
    Sobaniec W
    Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients.
    Privitera MD
    Ther Drug Monit; 1989 Nov; 11(6):647-51. PubMed ID: 2595745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between the serum levels of phenobarbital and diphenylhydantoin and clinical data in patients with drug resistant epilepsy.
    Bendarzewska-Nawrocka B; Pietruszewska E; Bacia T
    Monogr Neural Sci; 1980; 5():229-34. PubMed ID: 7322157
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of antiepileptic blood levels in the treatment of patients with epilepsy.
    Fincham RW; Schottelius DD
    J Iowa Med Soc; 1973 Sep; 63(9):433-6. PubMed ID: 4742131
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenytoin and phenobarbitone plasma clearance during pregnancy.
    Mygind KI; Dam M; Christiansen J
    Acta Neurol Scand; 1976 Aug; 54(2):160-6. PubMed ID: 821304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.